(Q98767346)

English

A randomized, double-blinded, placebo-controlled phase II clinical trial for Recombinant Novel Coronavirus (2019-nCOV) Vaccine (Adenovirus Vector)

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

A randomized, double-blinded, placebo-controlled phase II clinical trial for Recombinant Novel Coronavirus (2019-nCOV) Vaccine (Adenovirus Vector) in healthy adults aged above 18 years (English)

0 references

在18周岁及以上健康成人中开展重组新型冠状病毒(2019-nCOV)疫苗（腺病毒载体）随机、双盲、安慰剂对照设计的Ⅱ期临床试验 (Chinese)

0 references

country

People's Republic of China

0 references

start time

12 April 2020

0 references

end time

31 January 2021

0 references

number of participants

500

0 references

clinical trial phase

phase II clinical trial

0 references

exact match

http://www.chictr.org.cn/historyversionpuben.aspx?regno=ChiCTR2000031781

0 references

(Q98767346)

A randomized, double-blinded, placebo-controlled phase II clinical trial for Recombinant Novel Coronavirus (2019-nCOV) Vaccine (Adenovirus Vector)

Statements

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)